MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 15, 2006; DOI: 10.1124/mol.106.028662


0026-895X/07/7102-483-493$20.00
Mol Pharmacol 71:483-493, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028662v1
71/2/483    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kloda, J. H.
Right arrow Articles by Czajkowski, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kloda, J. H.
Right arrow Articles by Czajkowski, C.

Agonist-, Antagonist-, and Benzodiazepine-Induced Structural Changes in the {alpha}1 Met113-Leu132 Region of the GABAA Receptor

Jessica Holden Kloda1, and Cynthia Czajkowski

Department of Physiology and Molecular and Cellular Pharmacology Program, University of Wisconsin-Madison, Madison, Wisconsin

The structural basis by which agonists, antagonists, and allosteric modulators exert their distinct actions on ligand-gated ion channels is poorly understood. We used the substituted cysteine accessibility method to probe the structure of the GABAA receptor in the presence of ligands that elicit different pharmacological effects. Residues in the {alpha}1 Met113-Leu132 region of the GABA binding site were individually mutated to cysteine and expressed with wild-type beta2 and {gamma}2 subunits in Xenopus laevis oocytes. Using electrophysiology, we determined the rates of reaction of N-biotinaminoethyl methaneth-iosulfonate (MTSEA-biotin) with the introduced cysteines in the resting (unliganded) state and compared them with rates determined in the presence of GABA (agonist), 4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid hydrobromide (SR-95531; antagonist), pentobarbital (allosteric modulator), and flurazepam (allosteric modulator). {alpha}1N115C, {alpha}1L117C, {alpha}1T129C, and {alpha}1R131C are predicted to line the GABA binding pocket because MTSEA-biotin modification of these residues decreased the amount of current elicited by GABA, and the rates/extents of modification were decreased both by GABA and SR-95531. Reaction rates of some substituted cysteines were different depending on the ligand, indicating that barbiturate- and GABA-induced channel gating, antagonist binding, and benzodiazepine modulation induce specific structural rearrangements. Chemical reactivity of {alpha}1E122C was decreased by either GABA or pentobarbital but was unaltered by SR-95531 binding, whereas {alpha}1L127C reactivity was decreased by agonist and antagonist binding but not affected by pentobarbital. Furthermore, {alpha}1E122C, {alpha}1L127C, and {alpha}1R131C changed accessibility in response to flurazepam, providing structural evidence that residues in and near the GABA binding site move in response to benzodiazepine modulation.


Received July 7, 2006; accepted November 15, 2006

Address correspondence to: Dr. Cynthia Czajkowski, Department of Physiology, University of Wisconsin at Madison, 601 Science Drive, Madison, WI 53711. E-mail: czajkowski{at}physiology.wisc.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. M. Sharkey and C. Czajkowski
Individually Monitoring Ligand-Induced Changes in the Structure of the GABAA Receptor at Benzodiazepine Binding Site and Non-Binding-Site Interfaces
Mol. Pharmacol., July 1, 2008; 74(1): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Mercado and C. Czajkowski
{gamma}-Aminobutyric Acid (GABA) and Pentobarbital Induce Different Conformational Rearrangements in the GABAA Receptor {alpha}1 and {beta}2 Pre-M1 Regions
J. Biol. Chem., May 30, 2008; 283(22): 15250 - 15257.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. M. Hanson and C. Czajkowski
Structural Mechanisms Underlying Benzodiazepine Modulation of the GABAA Receptor
J. Neurosci., March 26, 2008; 28(13): 3490 - 3499.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Padgett and S. C. R. Lummis
The F-loop of the GABAA Receptor {gamma}2 Subunit Contributes to Benzodiazepine Modulation
J. Biol. Chem., February 1, 2008; 283(5): 2702 - 2708.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics